These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 2557629)

  • 1. Mapping the active-site tyrosine of vaccinia virus DNA topoisomerase I.
    Shuman S; Kane EM; Morham SG
    Proc Natl Acad Sci U S A; 1989 Dec; 86(24):9793-7. PubMed ID: 2557629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptide sequencing and site-directed mutagenesis identify tyrosine-727 as the active site tyrosine of Saccharomyces cerevisiae DNA topoisomerase I.
    Lynn RM; Bjornsti MA; Caron PR; Wang JC
    Proc Natl Acad Sci U S A; 1989 May; 86(10):3559-63. PubMed ID: 2542938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Covalent and noncovalent DNA binding by mutants of vaccinia DNA topoisomerase I.
    Morham SG; Shuman S
    J Biol Chem; 1992 Aug; 267(22):15984-92. PubMed ID: 1322412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutational analysis of vaccinia DNA topoisomerase defines amino acid residues essential for covalent catalysis.
    Wittschieben J; Shuman S
    J Biol Chem; 1994 Nov; 269(47):29978-83. PubMed ID: 7961997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of vaccinia virus DNA topoisomerase I expressed in Escherichia coli.
    Shuman S; Golder M; Moss B
    J Biol Chem; 1988 Nov; 263(31):16401-7. PubMed ID: 2846543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An engineered mutant of vaccinia virus DNA topoisomerase I is sensitive to the anti-cancer drug camptothecin.
    Gupta M; Zhu CX; Tse-Dinh YC
    J Biol Chem; 1992 Dec; 267(34):24177-80. PubMed ID: 1332948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific DNA cleavage and binding by vaccinia virus DNA topoisomerase I.
    Shuman S; Prescott J
    J Biol Chem; 1990 Oct; 265(29):17826-36. PubMed ID: 2170398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Site-specific interaction of vaccinia virus topoisomerase I with duplex DNA. Minimal DNA substrate for strand cleavage in vitro.
    Shuman S
    J Biol Chem; 1991 Jun; 266(17):11372-9. PubMed ID: 1645733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA strand transfer reactions catalyzed by vaccinia topoisomerase: hydrolysis and glycerololysis of the covalent protein-DNA intermediate.
    Petersen BO; Shuman S
    Nucleic Acids Res; 1997 Jun; 25(11):2091-7. PubMed ID: 9153307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical analysis of mutant alleles of the vaccinia virus topoisomerase I carrying targeted substitutions in a highly conserved domain.
    Klemperer N; Traktman P
    J Biol Chem; 1993 Jul; 268(21):15887-99. PubMed ID: 8393454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombination mediated by vaccinia virus DNA topoisomerase I in Escherichia coli is sequence specific.
    Shuman S
    Proc Natl Acad Sci U S A; 1991 Nov; 88(22):10104-8. PubMed ID: 1658796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Replacement of the active site tyrosine of vaccinia DNA topoisomerase by glutamate, cysteine or histidine converts the enzyme into a site-specific endonuclease.
    Wittschieben J; Petersen BO; Shuman S
    Nucleic Acids Res; 1998 Jan; 26(2):490-6. PubMed ID: 9421505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a vaccinia virus gene encoding a type I DNA topoisomerase.
    Shuman S; Moss B
    Proc Natl Acad Sci U S A; 1987 Nov; 84(21):7478-82. PubMed ID: 2823264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of DNA transesterification by vaccinia topoisomerase: catalytic contributions of essential residues Arg-130, Gly-132, Tyr-136 and Lys-167.
    Wittschieben J; Shuman S
    Nucleic Acids Res; 1997 Aug; 25(15):3001-8. PubMed ID: 9224599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and characterization of the orf virus type I topoisomerase.
    Klemperer N; Lyttle DJ; Tauzin D; Traktman P; Robinson AJ
    Virology; 1995 Jan; 206(1):203-15. PubMed ID: 7831775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutational analysis of 26 residues of vaccinia DNA topoisomerase identifies Ser-204 as important for DNA binding and cleavage.
    Wang LK; Wittschieben J; Shuman S
    Biochemistry; 1997 Jul; 36(26):7944-50. PubMed ID: 9201940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccinia topoisomerase mutants illuminate conformational changes during closure of the protein clamp and assembly of a functional active site.
    Krogh BO; Shuman S
    J Biol Chem; 2001 Sep; 276(39):36091-9. PubMed ID: 11441004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping of the active site tyrosine of eukaryotic DNA topoisomerase I.
    Eng WK; Pandit SD; Sternglanz R
    J Biol Chem; 1989 Aug; 264(23):13373-6. PubMed ID: 2547758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analogues of vaccinia virus DNA topoisomerase I modified at the active site tyrosine.
    Gao R; Zhang Y; Choudhury AK; Dedkova LM; Hecht SM
    J Am Chem Soc; 2005 Mar; 127(10):3321-31. PubMed ID: 15755148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletions at the carboxyl terminus of vaccinia DNA topoisomerase affect DNA binding and enhance distributivity in DNA relaxation.
    Wang LK; Shuman S
    Biochemistry; 1997 Apr; 36(13):3909-16. PubMed ID: 9092821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.